Navigation Links
Strativa Pharmaceuticals Acquires Commercialization Rights to Thin Film Formulation of Ondansetron From MonoSol Rx
Date:6/17/2008

Second Unique Formulation of Ondansetron in Portfolio

WOODCLIFF LAKE, N.J., June 17 /PRNewswire-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: PRX), and MonoSol Rx today announced that they have entered into an exclusive licensing agreement under which Strativa has acquired the commercialization rights in the United States and its territories to the thin film formulation of ondansetron from MonoSol Rx, a leader in oral thin film technology. Ondansetron thin film formulation is a new oral formulation in development for the prevention of chemotherapy-induced nausea and vomiting, prevention of nausea and vomiting associated with radiotherapy, and post-operative nausea and vomiting.

Based on the results of a recently completed pilot bio-equivalency study, MonoSol Rx is moving immediately to pivotal trials to enable application for drug approval in the U.S. Subject to favorable results, it is anticipated that Strativa could file an NDA with the appropriate regulatory authorities within the next twelve months.

Specific terms were not disclosed, but the agreement calls for milestone payments prior to commercial launch, payments for product supply, royalties and additional sales-based milestones on net sales of the product. Total milestone payments could be as high as $23.5 million.

Anti-emetic therapies constitute one of the largest segments of the supportive care market in the U.S., with annual sales of over $1.6 billion in 2007. Ondansetron was the prescription leader in the category in 2007, with 2.7 million scripts written.

John A. MacPhee, president of Strativa, said, "We are delighted to collaborate
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. MonoSol Rx Licenses Thin Film Formulation of Ondansetron to Strativa Pharmaceuticals, a Division of Par Pharmaceutical
2. Verus Pharmaceuticals Announces Divestiture of Pediatric GI Development Program to Meritage Pharma
3. Synovics Pharmaceuticals forms a Strategic Joint Venture with Maneesh Pharmaceuticals
4. Alseres Pharmaceuticals, Inc.s Chairman, Peter Savas, Reviews Companys Progress in its Annual Letter to Stockholders
5. Jazz Pharmaceuticals Announces Development Timeline Updates
6. GlaxoSmithKline Acquires Sirtris Pharmaceuticals, Inc., a World Leader in Sirtuin Research and Development
7. Renhuang Pharmaceuticals, Inc. Holds Trade Show for Tianma Pills; Signs Letters of Intent
8. Indevus Pharmaceuticals Provides Update on NEBIDO(R) NDA Status
9. MAP Pharmaceuticals to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
10. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on June 11, 2008 in New York
11. Antipodean Pharmaceuticals Announces FDA Acceptance of IND for MitoQ(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... York (PRWEB) May 21, 2013 Parker ... the rights of victims injured by defective medical devices, ... Bone & Joint Surgery on May 15, 2013. The ... used to identify complications that occur in patients with ... of failure. ( http://www.jbjs.org/article.aspx?articleid=1684770 ) , ...
(Date:5/21/2013)... 21, 2013 HealthSmart continues to grow ... presence has required the hiring of new talent in ... pleased to announce that Dawn Powell has joined the ... the Director of Account Management in the Central Region ... Irving, Texas. With extensive client management, employee benefits, and ...
(Date:5/21/2013)... results from SOURCE XT one of the largest, ... reported today at EuroPCR 2013 show good clinical outcomes ... success for all access approaches, valve sizes and delivery ... 2688 consecutively enrolled patients (mean age 81.5 years) undergoing ... centres in 17 countries between July 2010 and October ...
(Date:5/21/2013)... May 21, 2013 Arizona State ... who want to develop their ideas into solutions, ... , The university is recruiting participants for ... “formation space” that provides early-stage entrepreneurs with opportunities ... is open to anyone, ASU is particularly seeking ...
(Date:5/21/2013)... 2013 The federal judge overseeing the ... lawsuits in U.S. District Court, Northern District of ... request from Plaintiffs’ Counsel to conduct Ex Parte interviews ... 17th Order grants that request, and sets forth procedures ... Wright Medical Technology, Inc., Conserve Hip Implant Products Liability ...
Breaking Medicine News(10 mins):Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 2Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 3Health News:New Talent Joins the HealthSmart Account Management Team 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 3Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 4Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 2Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 3
... Most people who survive a stroke recover some degree ... months and years. This recovery is commonly believed to reflect ... brain damage. Now a new study, published in the February ... on the recovery process through its effect on language skills. ...
... Sphincter of Oddi dysfunction (SOD) is a pathological syndrome ... the pancreatic type according to the Milwaukee criteria. However, ... of which result in flawed classification and failure to ... published on January 21, 2011 in the World ...
... available in German . Nearly ten ... the patients do not respond to any established treatment method. ... of "brain pacemaker" has recently raised hopes: According to initial ... in this manner see a significant improvement in mood. Physicians ...
... ANN ARBOR, Mich. Are some children genetically tuned to ... Check-ups of 1,003 Michigan 6th graders in a school-based ... to consume school lunch instead of a packed lunch from ... playing a video game. The results were compiled by ...
... Clinical Cardiology reveals that a Super Bowl loss for ... men and women and in older individuals. , Sports fans may ... loses, it can cause some degree of emotional stress. , Led ... Samarian Hospital and Keck School of Medicine at USC in Los ...
... SATURDAY, Jan. 29 (HealthDay News) -- Dry eye syndrome is ... dry indoor heat, says an eye expert. Symptoms include ... watery eyes as the eyes try to compensate for the ... dry eye and allergies can cause watery eyes, differentiating the ...
Cached Medicine News:Health News:The changing roles of 2 hemispheres in stroke recovery 2Health News:Brain pacemakers: A long-lasting solution in the fight against depression 2Health News:Brain pacemakers: A long-lasting solution in the fight against depression 3Health News:Childhood obesity linked to health habits, not heredity: U-M study 2Health News:Dry Eye Syndrome Common in Winter 2
(Date:5/21/2013)... PHILADELPHIA , May 21, 2013 ... image and impressive new product developments at the Special Libraries ... ten years of unerring focus on product literature databases and ... to mark the occasion," said founding director Nigel ... interesting developments of benefit to our clients and what better ...
(Date:5/21/2013)... May 21, 2013  Zacks.com announces the list of ... Zacks Equity Research analysts discuss the latest news and ... featured in the blog include Actavis, Inc.,s (NYSE: ... SA (NYSE: TOT ), Petrobras (NYSE: PBR ... (Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO ) ...
(Date:5/21/2013)... -- IsoRay, Inc. (AMEX: ISR ), ( http://www.isoray.com/ ... exclusive international distribution agreement with IASIS Medical for the ... Greece . IsoRay is a medical technology company ... for brain cancer, lung cancer, head and neck cancer, ... IASIS Medical is ideally suited to support IsoRay,s products, ...
Breaking Medicine Technology:Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 3The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 2The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 3The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 4The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 5IsoRay Announces A New International Distributor For Greece 2IsoRay Announces A New International Distributor For Greece 3
Features soft, low friction sheath that extends beyond the tip....
Designed to retain the desired curve during oral intubation....
Stylet tube, endotracheal, sterile, stainless steel, malleable, one size, overall length 13"(33cm)....
SunGlide™ Stylette - Blue Neonatal. Use in 2.0 to 3.5mm tubes. 25/box....
Medicine Products: